Singh SK. ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY. SJHR-Africa [Internet]. 2023Dec.7 [cited 2024Oct.18];4(12):5. Available from: https://sjhresearchafrica.org/index.php/public-html/article/view/865